2-Aminoindane: Difference between revisions
>Oskykins m Text replacement - "*'''United Kingdom''' - This drug is illegal under the Psychoactive Substance Act, which came into effect on May 26th, 2016." to "*'''United Kingdom''' - This drug is illegal under the Psychoactive Substance Act, which came into effect on May 26th, 2016." |
>Josikins m Text replacement - " | https://www.ncbi." to " (PubMed.gov / NCBI) | https://www.ncbi." |
||
Line 5: | Line 5: | ||
| ''[[2-Aminoindane/Summary|Summary sheet: 2-Aminoindane]]'' | | ''[[2-Aminoindane/Summary|Summary sheet: 2-Aminoindane]]'' | ||
|} | |} | ||
'''2-Aminoindane''' ('''2-AI''') is a [[psychoactive drug]] and [[research chemical]] with [[psychoactive class::stimulant]] properties. It is an analogue of [[amphetamine]].<ref>Structural variation and (+)-amphetamine-like discriminative stimulus properties | https://www.ncbi.nlm.nih.gov/pubmed/2068194</ref> | '''2-Aminoindane''' ('''2-AI''') is a [[psychoactive drug]] and [[research chemical]] with [[psychoactive class::stimulant]] properties. It is an analogue of [[amphetamine]].<ref>Structural variation and (+)-amphetamine-like discriminative stimulus properties (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/2068194</ref> | ||
Very little is known about this substance, but it has recently become easily accessible through online [[research chemical]] vendors where it is being sold as a [[designer drug]]. | Very little is known about this substance, but it has recently become easily accessible through online [[research chemical]] vendors where it is being sold as a [[designer drug]]. |